Skip to main content

Orthocell boosts Marine Biomedical stake

16/01/2026 - 09:45

Bookmark

Save articles for future reference.

Orthocell has finalised a move to boost its stake in Marine Biomedical, the company developing a bone substitute using Kimberley pearls, simultaneously securing global distribution rights.

X

To read our articles you will need to either login or subscribe.